ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation

NCT07015853 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

TNBC - Triple-Negative Breast Cancer
Breast Cancer

Interventions

DRUG: Pembrolizumab
RADIATION: Radiotherapy
DRUG: Axatilimab

Sponsor

Stephen Shiao

Collaborators

[object Object]
[object Object]